1. Velikova T, Georgiev T. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatol Int. 2021; 41(3):509–518. PMID:
33515320.
Article
2. Vadalà M, Poddighe D, Laurino C, Palmieri B. Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? EPMA J. 2017; 8(3):295–311. PMID:
29021840.
Article
3. Gelzo M, Cacciapuoti S, Pinchera B, De Rosa A, Cernera G, Scialò F, et al. A Transient increase in the serum ANCAs in patients with SARS-CoV-2 infection: a signal of subclinical vasculitis or an epiphenomenon with no clinical manifestations? A pilot study. Viruses. 2021; 13(9):1718. PMID:
34578298.
Article
4. Prabhahar A, Naidu GS, Chauhan P, Sekar A, Sharma A, Sharma A, et al. ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review. Rheumatol Int. 2022; 42(4):749–758. PMID:
35124725.
Article
5. Walsh M, Merkel PA, Peh CA, Szpirt WM, Puéchal X, Fujimoto S, et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020; 382(7):622–631. PMID:
32053298.
Article
6. Shakoor MT, Birkenbach MP, Lynch M. ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis. 2021; 78(4):611–613. PMID:
34280507.
Article
7. Anderegg MA, Liu M, Saganas C, Montani M, Vogt B, Huynh-Do U, et al. De novo vasculitis after mRNA-1273 (Moderna) vaccination. Kidney Int. 2021; 100(2):474–476. PMID:
34087251.
Article
8. Davidovic T, Schimpf J, Sprenger-Mähr H, Abbassi-Nik A, Soleiman A, Zitt E, et al. Novo and relapsing glomerulonephritis following SARS-CoV-2 mRNA vaccination in microscopic polyangiitis. Case Rep Nephrol. 2021; 2021:8400842.
9. Mohammad AJ. An update on the epidemiology of ANCA-associated vasculitis. Rheumatology (Oxford). 2020; 59(Suppl 3):iii42–iii50. PMID:
32348522.
Article
10. Li NL, Coates PT, Rovin BH. COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation? Kidney Int. 2021; 100(5):959–965. PMID:
34534551.
Article
11. Turner JS, O’Halloran JA, Kalaidina E, Kim W, Schmitz AJ, Zhou JQ, et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021; 596(7870):109–113. PMID:
34182569.
Article
12. Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021; 21(4):195–197. PMID:
33674759.
Article
13. Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, et al. Homologous and heterologous Covid-19 booster vaccinations. N Engl J Med. 2022; 386(11):1046–1057. PMID:
35081293.
Article